DOJ Greenlights UnitedHealth/Amedisys With Divestitures
August 7, 2025
By: Ben Remaly
Global Competition Review
Axinn managing partner Jeny Maier was quoted in the Global Competition Review article, "DOJ Greenlights UnitedHealth/Amedisys With Divestitures."
Click here to access the publication. A subscription is required.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
IBA Annual Conference 2025
Speaking Engagement
Antitrust
GCR Live: Global Merger Control 2025
Speaking Engagement
Antitrust
Thomson Reuters 24th Annual Law Firm COO & CFO Forum
Speaking Engagement
LegalNEXT 2025
Speaking Engagement
Antitrust
Informa Antitrust Texas 2025
Speaking Engagement
Antitrust
ACI Forum on Pharma & Biotech Patent Litigation USA 2025
Speaking Engagement
Intellectual Property
MCCA Gala 2025
Sponsorship
Antitrust
Axinn Honored at the 2025 Transform Awards North America
Awards & Recognitions
Antitrust 101: Trial-Minded Antitrust Discovery
Webinar
Antitrust
Be Careful What You Wish For: Class Action Waivers and Arbitration Agreements Can Create Headaches if Not Carefully Drafted
Axinn Viewpoints
Litigation & Trials